TriSalus Life Sciences (TLSIW) News Today $1.21 -0.27 (-18.24%) As of 03/27/2025 10:31 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)March 27 at 8:21 AM | markets.businessinsider.com4TLSI : Examining the Future: TriSalus Life Sciences's Earnings OutlookMarch 26 at 11:55 PM | benzinga.comTriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System MappingMarch 26 at 8:40 AM | finance.yahoo.comLake Street Initiates Coverage of TriSalus Life Sciences (TLSI) with Buy RecommendationFebruary 14, 2025 | msn.comTriSalus Life Sciences Announces Key Appointments to Board of DirectorsFebruary 3, 2025 | finance.yahoo.comTriSalus Life Sciences bolsters board with two new membersFebruary 3, 2025 | msn.comTriSalus Life Sciences expands board, appoints new directorsFebruary 2, 2025 | msn.comTrisalus life sciences CEO buys $50,302 in stockJanuary 30, 2025 | msn.comTrisalus life sciences director Sean Murphy buys $157,200 in stockJanuary 30, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: Align Tech (ALGN), TriSalus Life Sciences (TLSI)January 24, 2025 | markets.businessinsider.comTriSalus Life Sciences sees Q4 revenue $8.3M, consensus $8.04MJanuary 23, 2025 | markets.businessinsider.comRoth expects ‘continued strong execution’ from TriSalus under new CFOJanuary 10, 2025 | markets.businessinsider.comTriSalus Life Sciences announces publication of pre-clinical dataJanuary 10, 2025 | finance.yahoo.comTriSalus Life Sciences Taps James Young as CFOJanuary 8, 2025 | marketwatch.comTriSalus Announces Leadership ChangesJanuary 8, 2025 | finance.yahoo.comTriSalus Life Sciences appoints James Young CFO, Richard Marshak CCOJanuary 8, 2025 | markets.businessinsider.comJonesTrading Remains a Buy on TriSalus Life Sciences (TLSI)January 8, 2025 | markets.businessinsider.comCantor Fitzgerald Initiates Coverage of TriSalus Life Sciences (TLSI) with Overweight RecommendationDecember 17, 2024 | msn.comTriSalus Life Sciences management to meet with MaximDecember 11, 2024 | markets.businessinsider.comTrisalus life sciences director Mats Wahlstrom buys $47,056 in stockNovember 24, 2024 | investing.comTriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comTriSalus Life Sciences: Strong Buy Recommendation Supported by Robust Financial Growth and Strategic AdvancementsNovember 15, 2024 | markets.businessinsider.comTriSalus Life Sciences Reports Strong Q3 GrowthNovember 15, 2024 | markets.businessinsider.comTriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comTriSalus Reports Q3 2024 Financial Results and Provides Business UpdateNovember 14, 2024 | finance.yahoo.comA Look Ahead: TriSalus Life Sciences's Earnings ForecastNovember 13, 2024 | benzinga.comTriSalus Life Sciences files to sell 10.59M shares of common stock for holdersOctober 31, 2024 | markets.businessinsider.comNorthland Capital Markets Initiates Coverage of TriSalus Life Sciences (TLSI) with Outperform RecommendationOctober 26, 2024 | msn.comTriSalus Life Sciences initiated with an Outperform at NorthlandOctober 26, 2024 | markets.businessinsider.comOppenheimer Initiates Coverage of TriSalus Life Sciences (TLSI) with Outperform RecommendationSeptember 17, 2024 | msn.comTriSalus Life Sciences, Inc. Q1 Loss ClimbsMay 15, 2024 | markets.businessinsider.comTriSalus Life Sciences reports Q1 GAAP EPS of -$0.60, revenue of $6.5MMay 15, 2024 | msn.comTLSI Stock Earnings: TriSalus Life Sciences Misses EPS, Beats Revenue for Q4 2023April 1, 2024 | investorplace.com Remove Ads Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter. Email Address TLSIW Media Mentions By Week TLSIW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLSIW News Sentiment▼0.470.78▲Average Medical News Sentiment TLSIW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLSIW Articles This Week▼40▲TLSIW Articles Average Week Remove Ads Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSIW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRTSW News IONM News HSCSW News BEATW News LUCYW News IINNW News MDAIW News GEHC News PHG News ZBH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLSIW) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.